Guardant Health Applauds New Law Ensuring Access to Colorectal Cancer Screening Innovations with No Cost-Sharing for Pennsylvanians
Pennsylvania enacted HB 1123, aligning insurance coverage for colorectal cancer screening with ACS and NCCN guidelines and eliminating cost-sharing for roughly 2 million screening-eligible Pennsylvanians. The law applies to state-regulated plans and Medicaid, takes effect December 21, 2026, and directly expands access to Guardant Health's Shield blood test.
Key figures
- Effective date
- December 21, 2026
- Eligible population
- about 2 million Pennsylvanians of screening-eligible age
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.